Personal and lifestyle characteristics of participants at baseline, including prescribed drug usage, according to treatment group.a
| Hawthorn (n = 39) (95% CI) | Placebo (n = 40) (95% CI) | |
|---|---|---|
| Sex: males/females (n) | 27/12 | 28/12 |
| Age (years) | 62.6 (60.07 to 65.13) | 61.3 (58.16 to 64.44) |
| Body mass index (kg/m2)b | 28.8 (27.55 to 30.05) | 30.2 (28.79 to 31.61) |
| Exercise: ‘moderate’ to ‘great’/‘hardly any’ to ‘light’ (%) | 40/60 | 45/55 |
| Stress: ‘moderate’ to ‘great’/‘not stressful’ (%) | 57.5/42.5 | 45/55 |
| Smoking: yes/no (%) | 2.5/97.5 | 2.5/97.5 |
| Waist circumference: males (cm)c | 104.0 (100.10 to 107.90) | 105.0 (101.5 to 108.05) |
| Waist circumference: females (cm)d | 98.6 (93.36 to 103.84) | 102.5 (96.06 to 108.94) |
| Waist to hip ratio: males (n)e | 0.97 (0.95 to 0.99) | 0.97 (0.95 to 0.99) |
| Waist to hip ratio: females (n)f | 0.89 (0.85 to 0.93) | 0.89 (0.86 to 0.92) |
| Participants on hypoglycaemic medication (n) | ||
| Low-dose insulin | 4 | 3 |
| Metformin | 19 | 20 |
| Gliclazide | 12 | 16 |
| Others | 6 | 7 |
| Participants on hypotensive medication (n) | ||
| ACE inhibitors | 19 | 15 |
| Calcium channel blockers | 8 | 10 |
| β-blockers | 6 | 7 |
| Diuretics | 10 | 4 |
| Others | 2 | 4 |